Cover Image

SMALL CELL CARCINOMA OF PROSTATE A CASE REPORT

HEMALATHA KRISHNASAMY

Abstract


Small cell carcinoma of prostate is a rare
malignant tumour of prostate. The therapeutic
implications of this finding are of
significance because tumours demonstrating
this phenotype usually represent
an inherently endocrine-resistant subtype
and, in view of their different clinical and
biologic properties compared with the
usual adenocarcinoma of the prostate,
these tumours usually require different
treatment strategies.


Full Text:

PDF

References


Wagner D G, Cheng L. Pathology of

small cell prostate carcinoma. 8th June

emedicine.medscape.com/

article/1611899-overview].

Aoki H, Ishidoya S, Ito A, Endoh M,

Shimazui T, Arai Y. Experience of the

treatment with gemcitabin, docetaxel, and

carboplastin (CDC) chemotherapy for patients

with small-cell carcinoma of the

prostate. Int J Urol 2006; 13(9): 1254 –

Wang W, Epstein JI. Small cell carcinoma

of the prostate. A morphologic and

immunohistochemical study of 95 cases.

Am J Surg Pathol 2008;32:65-71.

Albisinni S, De Nunzio C, Tubaro A.

Pure small cell carcinoma of the prostate:

A rare tumor. Indian J Urol 2012;28:89-91

Ketata S, Ketata H, Fakhfakh H, Sahnoun

A, Bahloul A, Boudawara T, et al.

Pure primary neuroendocrine tumor of

the prostate: A rare entity. Clin Genitourin

Cancer 2006;5:82-4.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University